Stock News
Unlocking the Benefits of AccessWire: A Comprehensive Guide to Maximizing Your Online Presence
CureVac Announces First Clinical Data from CVGBM Cancer Vaccine Study TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / September 9, 2024 CureVac N.V. (Nasdaq:CVAC), a global biopharmaceutical company specializing in messenger ribonucleic acid (“mRNA”) based medicines, has revealed that the initial clinical findings from their Phase 1 CVGBM cancer vaccine study in patients with resected…
Breaking News: Terns Pharmaceuticals Reports Promising Results from Phase 1 Clinical Trial of TERN-601, a Revolutionary Once-Daily Oral GLP-1R Agonist for Obesity Treatment
Positive Results from Terns Pharmaceuticals Phase 1 Trial for TERN-601 Statistically Significant Weight Loss and Well-Tolerated Drug Terns Pharmaceuticals, Inc. recently announced positive top-line data from its Phase 1 trial for TERN-601. The trial showed statistically significant mean weight loss of up to 5.5% over 28 days, with a 4.9% placebo adjustment. This is a…
Get Ready to Blast Off: MoonLake Immunotherapeutics’ Out-of-This-World Capital Markets Update on September 11th!
Welcome to MoonLake Immunotherapeutics’ Capital Markets Update! What to Expect Get ready for an exciting event as MoonLake Immunotherapeutics AG gears up to host a Capital Markets Update for investors and analysts. This live event will take place on Wednesday, September 11, 2024, from 9:00 – 10:30 EST in New York, and will feature key…
Clever, Personable, and Unconventional: Relay Therapeutics Shares Positive Interim Data for RLY-2608, Showing Significant Progression-Free Survival
Exciting Updates in the Treatment of Metastatic Breast Cancer RP2D Shows Promising Results in Metastatic Breast Cancer Patients Recently, there have been groundbreaking developments in the treatment of metastatic breast cancer, particularly in patients with PI3Kα-mutated, HR+/HER2- mutations. The latest data has shown a remarkable 9.2-month median PFS in heavily pre-treated patients who received RP2D…
Gold Strikes Gold: Lavras Gold Corp. Unearths 2.9 g/t of Gold Over 59 Metres at Fazenda do Posto Target in Brazil’s LDS Project – Plus Exciting Exploration Update!
Exciting Gold Discoveries at Fazenda do Posto Gold Target in Brazil Lavras Gold Corp. Releases Impressive Drill Results Toronto, Ontario–(Newsfile Corp. – September 9, 2024) – Lavras Gold Corp. (TSXV: LGC) (OTCQX: LGCFF) (“Lavras Gold” or the “Company”) is pleased to release the results from 12 new drillholes testing the Fazenda do Posto Gold Target,…
Innovative and Articulate: GoviEx Uranium Expands Presence in Zambia
GoviEx secures option to acquire 51% of the Lundazi exploration license Acquisition is part of the strategy to increase exploration footprint within Zambia, targeting Karoo hosted Uranium GoviEx already possesses substantial exploration data for the area Vancouver, British Columbia–(Newsfile Corp. – September 9, 2024) – GoviEx Uranium Inc. (TSXV: GXU) (OTCQX: GVXXF) (“GoviEx” or “Company”)…
Innovative, Articulate, and Easy to Follow: Ellomay Capital Reaches Major Milestone in Project Finance for 198 MW Solar Portfolio in Italy
Welcome to the Future of Renewable Energy with Ellomay Capital Ltd. Innovative Financing for Solar Projects in Italy Tel-Aviv, Israel, Sept. 09, 2024 (GLOBE NEWSWIRE) — Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel, and…
Unleashing the Power of Play: How The Gap Inc. is Bouncing Back and Winning Hearts
Gap, Inc.: A Bright Future Ahead New Leadership and Strategic Changes Gap, Inc. is on the brink of exciting growth with the appointment of new leadership and strategic changes in place. With a focus on driving sales and earnings growth, the company is set to make a significant impact in the retail industry. CEO Richard…